The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Urgent Treatment of Early-Onset Severe Toxicity of 5-FU or Capecitabine
OBJECTIVES
Describe the incidence and burden of early-onset severe toxicity in patients receiving 5-FU and capecitabine
Describe mechanism of action of 5-FU and its cytotoxic metabolites as it relates to the causes of early-onset severe toxicity
Recognize signs and symptoms of 5-FU and capecitabine early-onset severe toxicity
Summarize evidence supporting emergency treatment for patients with early-onset severe toxicity and following 5-FU or capecitabine overdoses
Review the importance of prompt treatment of overdoses and early-onset severe toxicity
Educate patients, caregivers, and colleagues about the importance of recognizing and urgently treating early-onset severe toxicity of 5-FU or capecitabine
Speaker:
Alice Beers, BSN, OCN, RN-BC Oncology Nurse Navigator MedStar Georgetown Cancer Network at Washington Cancer Institute MedStar Washington Hospital Center Washington, DC
You must be logged in and own this session in order to
post comments.